Mark Lawler: 10 years since we launched European Cancer Patient’s Bill of Rights

Mark Lawler shared a post on X:

“10 years since we launched European Cancer Patient’s Bill of Rights. Its Europe-wide impact was recognised by the European Health Award and it underpinned the European Code of Cancer Practice highlighting what we should expect from our health systems. 4P-CAN continues that journey.”

Source: Mark Lawler/X

Professor Mark Lawler holds the positions of Associate Pro-Vice-Chancellor, Professor of Digital Health, and Chair in Translational Cancer Genomics at the Faculty of Medicine, Health and Life Sciences at Queen’s University Belfast (QUB). He serves on the Board of the European Alliance for Personalised Medicine (EAPM) and was instrumental in developing EAPM’s research strategy.

Additionally, he is a member of the Scientific Advisory Board of the European Cancer Patient Coalition and the Strategic Advisory Board of Genomics England. His expertise includes genetics, precision medicine, health data, COVID-19, cancer, and patient and public involvement in research.